Blood or sputum eosinophils to guide asthma therapy?
- 1 November 2015
- journal article
- editorial
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 3 (11) , 824-825
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Blood eosinophil count and prospective annual asthma disease burden: a UK cohort studyThe Lancet Respiratory Medicine, 2015
- High blood eosinophil counts predict sputum eosinophilia in patients with severe asthmaJournal of Allergy and Clinical Immunology, 2015
- High blood eosinophil count is associated with more frequent asthma attacks in asthma patientsAnnals of Allergy, Asthma & Immunology, 2014
- Importance of concomitant local and systemic eosinophilia in uncontrolled asthmaEuropean Respiratory Journal, 2014
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialThe Lancet, 2012
- Mepolizumab for Prednisone-Dependent Asthma with Sputum EosinophiliaNew England Journal of Medicine, 2009
- Predictors of Loss of Asthma Control Induced by Corticosteroid WithdrawalCanadian Respiratory Journal, 2006
- Prednisone-dependent asthma: inflammatory indices in induced sputumEuropean Respiratory Journal, 1999
- Eosinophilic Inflammation in AsthmaNew England Journal of Medicine, 1990
- Total Eosinophil Counts in the Management of Bronchial AsthmaNew England Journal of Medicine, 1975